NCT07363148

A Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

A Randomized, Double-blind, Placebo-controlled, Parallel Clinical Trial to Investigate the Safety and Efficacy of MB-1 on Metabolic Health in Overweight and Obese Adults

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Arrae · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to investigate the safety and efficacy of MB-1 on metabolic health in overweight and obese adults. The main question it aims to answer is: What is the difference in change in body weight and body mass index (BMI) from baseline at Day 84 between MB-1 and placebo? Participants will be provided MB-1 or placebo and be assessed for anthropometric measurements, blood pressure, heart rate, and asked to complete appetite and satiety questionnaires and undergo a DEXA scan.

Conditions

• Obese
• Overweight Adults
• Obese Adults
• Body Weight Control
• BMI

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	MB-1	Participants will be instructed to take two capsules every morning with a meal for the duration of the study starting on Day 1.
OTHER	Placebo	Participants will be instructed to take two capsules every morning with a meal for the duration of the study starting on Day 1.

Timeline

• Start date: 2026-04-01
• Primary completion: 2026-04-01
• Completion: 2026-07-01
• First posted: 2026-01-23
• Last updated: 2026-01-26

Locations

1 site across 1 country: Canada